Technical Analysis for VIE - Viela Bio, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | N/A | Down | Down |
| Historical VIE trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Multiple of Ten Bullish | Other | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Down 4 Days in a Row | Weakness | 0.00% | |
| Multiple of Ten Bullish | Other | -3.26% | |
| Wide Bands | Range Expansion | -3.26% | |
| Down 3 Days in a Row | Weakness | -3.26% | |
| Wide Bands | Range Expansion | -15.61% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -18.89% | |
| NR7 | Range Contraction | -18.89% |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 03/25/2020
- Sector: Healthcare
- Industry: Biotechnology
Viela Bio, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatment for autoimmune and inflammatory diseases. Its lead product candidate, inebilizumab, is a humanized monoclonal antibody (mAb), designed to target CD19, a molecule expressed on the surface of a broad range of immune system B cells. The company was founded on December 11, 2017 and is headquartered in Gaithersburg, MD.
Medicine Biotechnology Medical Specialties Monoclonal Antibodies Autoimmune And Inflammatory Diseases Humanized Antibody Tolerx Monoclonal Antibody Therapy
Medicine Biotechnology Medical Specialties Monoclonal Antibodies Autoimmune And Inflammatory Diseases Humanized Antibody Tolerx Monoclonal Antibody Therapy
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 70.66 |
| 52 Week Low | 18.2 |
| Average Volume | 89,857 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 40.15 |
| 20-Day Moving Average | 37.50 |
| 10-Day Moving Average | 35.15 |
| Average True Range | 6.99 |
| ADX | 17.92 |
| +DI | 18.38 |
| -DI | 19.56 |
| Chandelier Exit (Long, 3 ATRs ) | 36.99 |
| Chandelier Exit (Short, 3 ATRs ) | 45.99 |
| Upper Bollinger Band | 51.73 |
| Lower Bollinger Band | 23.26 |
| Percent B (%b) | 0.27 |
| BandWidth | 75.95 |
| MACD Line | -1.97 |
| MACD Signal Line | -1.49 |
| MACD Histogram | -0.4768 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 39.72 | ||||
| Resistance 3 (R3) | 39.60 | 36.52 | 38.23 | ||
| Resistance 2 (R2) | 36.52 | 34.25 | 36.58 | 37.74 | |
| Resistance 1 (R1) | 33.67 | 32.86 | 32.13 | 33.79 | 37.24 |
| Pivot Point | 30.59 | 30.59 | 29.82 | 30.65 | 30.59 |
| Support 1 (S1) | 27.74 | 28.32 | 26.20 | 27.86 | 24.40 |
| Support 2 (S2) | 24.66 | 26.93 | 24.72 | 23.90 | |
| Support 3 (S3) | 21.81 | 24.66 | 23.41 | ||
| Support 4 (S4) | 21.93 |
